The SynCardia Total Artificial Heart is a treatment option for cardiac transplant-eligible patients at risk of imminent death from biventricular failure. Medical Advice Disclaimer DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE The information, including but not limited to, text, graphics, ima...
The Syncardia Total Artificial Heart (TAH-t) obviates the criterion for single-sided support by actually excising both ventricles and supporting right- and left-sided circulation. As such, it also removes the offending substrate and minimizes the pharmacologic support required of pure assist devices....
SynCardia Systems, Inc. is the Tucson-based manufacturer of the world’s only FDA, Health Canada and CE approved Total Artificial Heart: the SynCardia temporary Total Artificial Heart. There have been more than 850 implants of the Total Artificial Heart, accounting for more than 190 patient years...
SYNCARDIA TEMPORARY TOTAL ARTIFICIAL HEART产品名称,P030011 S022申请号,pma申请类型,SYNCARDIA SYSTEMS, LLC申请人,数据来源于药智数据美国上市器械数据库。
The SynCardia freedom driver: A portable driver for discharge home with the total artificial heart The SynCardia freedom driver: a portable driver for dis- charge home with the total artificial heart. J Heart Lung Transplant. 2011;30(7):844-845... DE Jaroszewski,EM Anderson,CN Pierce,... ...
公司简介SynCardia Systems, Inc. is a medical technology company focused on developing, manufacturing and commercializing the SynCardia temporary Total Artificial Heart, or TAH-t, an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart...
Similar Companies Hiring Mochi Health Telehealth • Healthtech 2 Offices 70 Employees Cencora Pharmaceutical • Logistics • Healthtech 12 Offices 46000 Employees Stepful Software • Healthtech • Edtech • Artificial Intelligence New York, New York ...
SynCardia开发、制造和商业化SynCardia Total Artificial Heart(TAH),这是一个植入式系统,旨在承担衰竭或衰竭的人类心脏的全部功能。这是美国食品药品监督管理局批准的第一个也是唯一一个在美国和加拿大商业化的TAH。SynCardia的TAH及其前身在临床使用39年,已在全球140个医疗中心的2000多个植入中使用,它是世界上最广泛...
NeoChord focuses on beating heart mitral valve repair within the healthcare sector. The company offers the neochord artificial chordae delivery system, an echo-guided treatment for mitral valve regurgitation. It provides consultation services and resources for patients and healthcare professionals. NeoChord...
One notable artificial heart currently in use as an implant for patients waiting for a heart transplant is the Total Artificial Heart manufactured by SynCardia Systems, Inc., of Tucson, Ariz. Designed to operate much the same way as a human heart, this artificial heart replaces the two active...